Computer Science · Artificial Intelligence
Smart biosurface® technology for prostate cancer detection and risk stratification through CTC enumeration and biomarker expression profiling
Francesca Senic-Matuglia, Sabrina Picocci, G Franchi, Marzia Luigia De Marni, Laurent Golé, Daniele Robesti, Leonardo Quarta, Vito Cucchiara, Alberto Briganti, Roberta Carbone
See on the mapAbstract
correlation coefficients were calculated to evaluate the consistency of changes over time.Differentially expressed (DE) miRNAs were recognized by comparing preoperative samples with postoperative samples.Statistical significance was decided using a p-value threshold of <0.05.Results: The fold changes in miRNA expression at postoperative 6 months were generally matched with those at postoperative 3 months (Pearson correlation coefficient 0.76).Several DE miRNAs were recognized, with 5 miRNAs significantly upregulated at postoperative 3 months and 6 miRNAs significantly upregulated and 1 miRNA downregulated at postoperative 6 months.Particularly, miR-339-5p, miR-432-5p, and miR-335-3p revealed consistent upregulation at postoperative both 3-and 6-month, while their expression decreased at advanced stages based on preoperative data.In addition, miR-629-3p exhibited significant downregulation at postoperative 6 months, contrasting with its increased expression at advanced stages.These findings demonstrate that these miRNAs may play crucial roles in lung cancer progression and could serve as potential biomarkers for lung cancer diagnosis. Conclusion:The identified miRNAs, particularly miR-339-5p, miR-432-5p, miR-335-3p, and miR-629-3p, indicate promising associations with lung cancer diagnosis and progression, highlighting their potential as biomarkers for clinical management in lung cancer patients.Further validation trials are demanded to confirm their utility and specificity in clinical settings.